Pfizer Earnings: After Solid Results, Reaffirmed 2025 Guidance
Pfizer’s PFE 2024 revenue reached $63.6 billion, near the high end of its $61 billion-$64 billion guidance range. Management ...
Zacks.com on MSN3h
Pentair Earnings & Sales Surpass Estimates in Q4, EPS Up Y/Y
Pentair plc PNR reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.08, which beat the Zacks Consensus ...
AstraZeneca Sales, Core EPS Seen Rising -- Earnings Preview
CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.
Pfizer Beats Q4 Revenue, EPS Estimates
Pfizer reported robust fourth-quarter 2024 earnings, exceeding expectations in both revenue and adjusted earnings.